Kyverna Therapeutics Inc
KYTX3.420USD
-0.020-0.58%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
147.81MMarket Cap
LossP/E TTM
Kyverna Therapeutics Inc
3.420
-0.020-0.58%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q1
FY2022Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-75.96%-44.91M
-99.65%-37.06M
---27.49M
---24.18M
-122.77%-25.52M
-110.54%-18.56M
---11.46M
---8.82M
Net income from continuing operations
-67.22%-44.63M
-81.40%-37.49M
---34.49M
---28.80M
-139.55%-26.69M
-143.26%-20.67M
---11.14M
---8.50M
Operating gains losses
138.38%1.15M
21.86%563.00K
--558.00K
--530.00K
22.34%482.00K
23.53%462.00K
--394.00K
--374.00K
Other non-cash items
-671.54%-1.41M
-927.15%-1.55M
---2.22M
---1.59M
-19.61%246.00K
-153.93%-151.00K
--306.00K
--280.00K
Change in working capital
-18.82%-2.18M
-96.63%34.00K
--5.25M
--4.41M
-23.94%-1.84M
176.91%1.01M
---1.48M
---1.31M
-Change in prepaid expenses
85.23%-380.00K
15.23%-835.00K
---1.20M
--3.11M
-1498.14%-2.57M
-207.81%-985.00K
---161.00K
---320.00K
-Change in other current assets
-75.77%-515.00K
47.02%-960.00K
---663.00K
---39.00K
32.64%-293.00K
-214.58%-1.81M
---435.00K
---576.00K
-Change in other current liabilities
----
-188.89%-296.00K
--296.00K
----
----
141.83%333.00K
----
---796.00K
Cash from non-recurring investing activities
Cash from operating activities
-75.96%-44.91M
-99.65%-37.06M
---27.49M
---24.18M
-122.77%-25.52M
-110.54%-18.56M
---11.46M
---8.82M
Investing cash flow
Net cash from continuing investing activities
-100.00%0.00
59.28%532.00K
--102.00K
--1.03M
1839.29%543.00K
2683.33%334.00K
--28.00K
--12.00K
Capital expenditures
-100.00%0.00
59.28%532.00K
--102.00K
--1.03M
1839.29%543.00K
2683.33%334.00K
--28.00K
--12.00K
Net cash flow from disposal of fixed assets
-100.00%0.00
59.28%532.00K
--102.00K
--1.03M
1839.29%543.00K
2683.33%334.00K
--28.00K
--12.00K
Net cash flow from investment products
104.56%5.58M
-7.06%29.75M
--778.00K
---66.89M
-994.07%-122.34M
111.19%32.02M
--13.68M
--15.16M
Cash from non-current investing activities
Net cash flow from investing activities
104.54%5.58M
-7.76%29.22M
--676.00K
---67.92M
-999.88%-122.88M
109.16%31.68M
--13.65M
--15.15M
Financing cash flow
Cash flow from continuous financing activities
-100.12%-414.00K
85.01%-215.00K
---152.00K
---569.00K
234856.25%338.05M
-1305.88%-1.43M
---144.00K
---102.00K
Net cash flow from debt Issuance/repayment
-47.62%-341.00K
-12.79%-247.00K
---242.00K
---236.00K
-37.50%-231.00K
-51.03%-219.00K
---168.00K
---145.00K
Net cash flow from common stock issuance/repurchase
-100.00%0.00
--0.00
--0.00
--0.00
--341.17M
----
--0.00
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
--0.00
----
--0.00
Proceeds from stock option exercised by employees
-95.31%3.00K
-88.36%32.00K
--90.00K
--73.00K
166.67%64.00K
539.53%275.00K
--24.00K
--43.00K
Net cash flow from other financing activities
97.43%-76.00K
100.00%0.00
--0.00
---406.00K
---2.96M
---1.49M
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.12%-414.00K
85.01%-215.00K
---152.00K
---569.00K
234856.25%338.05M
-1305.88%-1.43M
---144.00K
---102.00K
Net cash flow
Beginning cash balance
175.97%97.17M
347.24%105.23M
--132.19M
--224.86M
-8.04%35.21M
--23.53M
--38.29M
--0.00
Current period cash flow changes
-120.96%-39.75M
-168.93%-8.05M
---26.96M
---92.67M
9137.46%189.65M
87.60%11.68M
--2.05M
--6.23M
Ending cash balance
-74.46%57.42M
175.97%97.17M
--105.23M
--132.19M
457.38%224.86M
465.38%35.21M
--40.34M
--6.23M
Free cash flow
-72.30%-44.91M
-98.94%-37.59M
---27.59M
---25.20M
-126.95%-26.07M
-114.03%-18.90M
---11.49M
---8.83M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
